174 related articles for article (PubMed ID: 23338559)
1. Clinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease.
Soeda S; Ohyashiki JH; Ohtsuki K; Umezu T; Setoguchi Y; Ohyashiki K
Int J Mol Med; 2013 Mar; 31(3):533-9. PubMed ID: 23338559
[TBL] [Abstract][Full Text] [Related]
2. Gene expression networks in COPD: microRNA and mRNA regulation.
Ezzie ME; Crawford M; Cho JH; Orellana R; Zhang S; Gelinas R; Batte K; Yu L; Nuovo G; Galas D; Diaz P; Wang K; Nana-Sinkam SP
Thorax; 2012 Feb; 67(2):122-31. PubMed ID: 21940491
[TBL] [Abstract][Full Text] [Related]
3. An increased ratio of serum miR-21 to miR-181a levels is associated with the early pathogenic process of chronic obstructive pulmonary disease in asymptomatic heavy smokers.
Xie L; Wu M; Lin H; Liu C; Yang H; Zhan J; Sun S
Mol Biosyst; 2014 May; 10(5):1072-81. PubMed ID: 24556821
[TBL] [Abstract][Full Text] [Related]
4. Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease.
Akbas F; Coskunpinar E; Aynaci E; Oltulu YM; Yildiz P
Exp Lung Res; 2012 Aug; 38(6):286-94. PubMed ID: 22686440
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease.
Van Pottelberge GR; Mestdagh P; Bracke KR; Thas O; van Durme YM; Joos GF; Vandesompele J; Brusselle GG
Am J Respir Crit Care Med; 2011 Apr; 183(7):898-906. PubMed ID: 21037022
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease.
Song J; Wang QH; Zou SC
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4319-4324. PubMed ID: 30024625
[TBL] [Abstract][Full Text] [Related]
7. Peripheral leukocyte microRNAs as novel biomarkers for COPD.
Wang R; Xu J; Liu H; Zhao Z
Int J Chron Obstruct Pulmon Dis; 2017; 12():1101-1112. PubMed ID: 28435243
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Profiling Reveals a Role for MicroRNA-218-5p in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
Conickx G; Mestdagh P; Avila Cobos F; Verhamme FM; Maes T; Vanaudenaerde BM; Seys LJ; Lahousse L; Kim RY; Hsu AC; Wark PA; Hansbro PM; Joos GF; Vandesompele J; Bracke KR; Brusselle GG
Am J Respir Crit Care Med; 2017 Jan; 195(1):43-56. PubMed ID: 27409149
[TBL] [Abstract][Full Text] [Related]
9. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic analysis of microRNA and mRNA Regulation in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease.
Dang X; Qu X; Wang W; Liao C; Li Y; Zhang X; Xu D; Baglole CJ; Shang D; Chang Y
Respir Res; 2017 Jan; 18(1):4. PubMed ID: 28057018
[TBL] [Abstract][Full Text] [Related]
11. Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.
Linja-aho A; Mazur W; Toljamo T; Nieminen P; Ohlmeier S; Rönty M; Kinnula VL
APMIS; 2013 Jan; 121(1):11-21. PubMed ID: 23030783
[TBL] [Abstract][Full Text] [Related]
12. Plasma miRNAs might be promising biomarkers of chronic obstructive pulmonary disease.
Wang M; Huang Y; Liang Z; Liu D; Lu Y; Dai Y; Feng G; Wang C
Clin Respir J; 2016 Jan; 10(1):104-11. PubMed ID: 25102970
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
[TBL] [Abstract][Full Text] [Related]
14. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.
Vernooy JH; Küçükaycan M; Jacobs JA; Chavannes NH; Buurman WA; Dentener MA; Wouters EF
Am J Respir Crit Care Med; 2002 Nov; 166(9):1218-24. PubMed ID: 12403691
[TBL] [Abstract][Full Text] [Related]
15. Sex hormone alterations and systemic inflammation in a group of male COPD smokers and their correlation with the +138 insA/delA endothelin-1 gene polymorphism. A case-control study.
Kaparianos A; Argyropoulou E; Efremidis G; Spiropoulos K
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1149-57. PubMed ID: 22165675
[TBL] [Abstract][Full Text] [Related]
16. Plasma Extracellular Vesicle miRNAs Can Identify Lung Cancer, Current Smoking Status, and Stable COPD.
O'Farrell HE; Bowman RV; Fong KM; Yang IA
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071592
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs in plasma of patients with gastric cancers.
Tsujiura M; Ichikawa D; Komatsu S; Shiozaki A; Takeshita H; Kosuga T; Konishi H; Morimura R; Deguchi K; Fujiwara H; Okamoto K; Otsuji E
Br J Cancer; 2010 Mar; 102(7):1174-9. PubMed ID: 20234369
[TBL] [Abstract][Full Text] [Related]
18. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers.
Löfdahl JM; Wahlström J; Sköld CM
Clin Exp Immunol; 2006 Sep; 145(3):428-37. PubMed ID: 16907910
[TBL] [Abstract][Full Text] [Related]
19. Ectopic expressed miR-203 contributes to chronic obstructive pulmonary disease via targeting TAK1 and PIK3CA.
Shi L; Xin Q; Chai R; Liu L; Ma Z
Int J Clin Exp Pathol; 2015; 8(9):10662-70. PubMed ID: 26617776
[TBL] [Abstract][Full Text] [Related]
20. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking.
Nowak D; Kasielski M; Antczak A; Pietras T; Bialasiewicz P
Respir Med; 1999 Jun; 93(6):389-96. PubMed ID: 10464820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
